Mina Nakama

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.

Ryuichi Morishita, Gary H. Gibbons, Masatsugu Horiuchi et al. · Proceedings of the National Academy of Sciences · 1995 · 482 citations · Full text

Medicine, Genetics, Molecular Biology +15

A specific CpG site demethylation in the human interleukin 2 gene promoter is an epigenetic memory

Akiko Murayama, Kazuhisa Sakura, Mina Nakama et al. · The EMBO Journal · 2006 · 177 citations · Full text

Life Sciences, Immunology, Molecular Biology +13

DNA–RNA hybrid formation mediates RNAi‐directed heterochromatin formation

Mina Nakama, Kei Kawakami, Takuya Kajitani et al. · Genes to Cells · 2012 · 118 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

Deficiency of 3‐hydroxybutyrate dehydrogenase (BDH1) in mice causes low ketone body levels and fatty liver during fasting

Hiroki Otsuka, Takeshi Kimura, Yasuhiko Ago et al. · Journal of Inherited Metabolic Disease · 2020 · 47 citations · Full text

Life Sciences, Biochemistry, Nutritional Sciences +16

Exon 10 skipping in ACAT1 caused by a novel c.949G>A mutation located at an exonic splice enhancer site

Hiroki Otsuka, Hideo Sasai, Mina Nakama et al. · Molecular Medicine Reports · 2016 · 26 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17